Drug intelligence / Profile preview

Fortia

Development stage: Unknown
Lead developer: GyneBio Pharma
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

**FORTIA** is a GyneBio Pharma vitamin-complex product marketed in Morocco. It is described as a vitamin and mineral supplement supplied as a sugar-free, orange-flavoured effervescent tablet for oral use, intended to provide nutritional vitamin supplementation and support correction or prevention of vitamin deficiency. GyneBio Pharma lists FORTIA in its marketed product portfolio as a vitamin complex. ([gynebiopharma.com](https://gynebiopharma.com/))

Brand names: FORTIA

Beyond the preview

Go deeper on Fortia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fortia.

Explore the full profile